CEOINSIDER
← Leaders

Said Darwazah

Chief Executive Officer, Hikma Pharmaceuticals · United Kingdom

✓ Verified current role· as of 2026-09-22

Said Darwazah is the CEO of Hikma Pharmaceuticals. Darwazah is based in the United Kingdom. Darwazah was born in 1957 and educated at INSEAD and Purdue University.

Jordanian pharmaceutical executive who joined Hikma Pharmaceuticals in 1981 and has served multiple terms as CEO and chairman. Holds a degree in Industrial Engineering from Purdue University and an MBA from INSEAD.

Recent developments

AI summary of recent coverage

Recent coverage has focused on significant challenges at Hikma Pharmaceuticals, with multiple reports in February 2026 detailing sharp declines in the company's share price following weaker-than-expected forecasts and withdrawn guidance. Earlier headlines from December 2025 indicated that Darwazah stepped down as chief executive with immediate effect amid profit forecast cuts and factory delays, with a successor subsequently announced in January 2026.

Summarized from the headlines below; see each source for the full story.

Born
May 1957
Education
INSEAD, Purdue University

Our coverage

On CEOInsider

No feature yet. When we publish a feature, interview or cover story on Said Darwazah, it will appear here — and tie into the news timeline.

Said Darwazah: FAQ

Who is Said Darwazah?
Said Darwazah is the Chief Executive Officer of Hikma Pharmaceuticals, based in United Kingdom.
What company does Said Darwazah lead?
Said Darwazah is CEO of Hikma Pharmaceuticals.
Where was Said Darwazah educated?
Said Darwazah studied at INSEAD, Purdue University.